- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Saptak Chem and Business Limited has submitted its Annual Report for FY 2024-25, revealing a net loss of Rs. 8.62 lakh, worsening from Rs. 3.47 lakh in the prior year, primarily due to higher expenses and minimal operational revenue. A major corporate development is the NCLT-approved capital reduction scheme, set to cancel 90% of equity shares, reducing total outstanding shares from 1.07 crore to 10.73 lakh. The company remains focused on trading in chemical and agricultural produce. Additionally, the company faces a Rs. 1.19 crore GST-related contingent liability from FY 2018-19, currently under appeal. The 46th Annual General Meeting has been announced to adopt the financial results and consider re-appointing a Managing Director.